Compare VanEck Junior Gold Miners (GDXJ) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Junior Gold Miners vs Tenet Healthcare Corporation — how do they compare? VanEck Junior Gold Miners trades at $112.99 (market cap $8.22B), while Tenet Healthcare Corporation trades at $262.03 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 2.6× VanEck Junior Gold Miners's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Junior Gold Miners for 41 Days and Tenet Healthcare Corporation for 15 Days on average.
| GDXJ | THC | |
|---|---|---|
Market Cap | $8.22B | $20.98B |
Volume | 3,212,198 | 428,008 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $156.19 | $280.77 |
52-Week Low | $87.56 | $161.37 |
Typical Hold Time | 41 Days | 15 Days |
Enterprise Value | — | $32.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDXJ, the VanEck Junior Gold Miners ETF, is trading at $109.14, down 3.88% on the day, reflecting a bearish technical signal with selling pressure across moving averages and oscillators. Recent news highlights multiple junior gold mining companies being added to the ETF's index, potentially increasing its diversification and appeal. The ETF's current price is near key support levels, with the overall market sentiment influenced by gold price volatility and sector-specific developments.
The outlook for GDXJ is cautious due to bearish technical indicators and sector volatility, though inclusion of new companies may enhance long-term growth potential. Key risks include gold price fluctuations, mining operational risks, and broader market sentiment shifts. Investment opportunity lies in potential gold price appreciation and ETF rebalancing benefits, but requires careful risk management.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
